Divi's Laboratories Limited (BOM:532488)

India flag India · Delayed Price · Currency is INR
5,909.50
+113.95 (1.97%)
At close: Mar 24, 2025
75.63%
Market Cap 1.53T
Revenue (ttm) 90.78B
Net Income (ttm) 20.67B
Shares Out n/a
EPS (ttm) 77.84
PE Ratio 74.18
Forward PE n/a
Dividend 30.00 (0.51%)
Ex-Dividend Date Aug 2, 2024
Volume 3,708
Average Volume 7,081
Open 5,778.55
Previous Close 5,795.55
Day's Range 5,778.50 - 5,929.00
52-Week Range 3,350.05 - 6,448.75
Beta n/a
RSI 50.82
Earnings Date May 23, 2025

About Divi's Laboratories

Divi's Laboratories Limited engages in the manufacture and sale of generic active pharmaceutical ingredients (APIs), intermediates, and nutraceuticals in India, North America, Asia, Europe, and internationally. The company also undertakes custom synthesis contract manufacturing services of APIs and intermediates; and supplies a range of carotenoids, such as beta carotene, astaxanthin, lycopene, and canthaxanthin, as well as other finished forms, including lutein, and vitamins to food, dietary supplement, and feed manufacturers industries. It al... [Read more]

Industry Medicinal Chemicals and Botanical Products
Founded 1990
Employees 9,741
Stock Exchange Bombay Stock Exchange
Ticker Symbol 532488
Full Company Profile

Financial Performance

In 2023, Divi's Laboratories's revenue was 78.45 billion, an increase of 1.00% compared to the previous year's 77.67 billion. Earnings were 16.00 billion, a decrease of -12.28%.

Financial Statements

News

There is no news available yet.